This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Mammoth Biosciences, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Matan Drory Retwitzer: Innovator in CRISPR Technology
Introduction
Matan Drory Retwitzer is a notable inventor based in Foster City, California. He has made significant contributions to the field of biotechnology, particularly in the development of effector proteins associated with CRISPR technology. His innovative work has the potential to impact various applications in genetic engineering and molecular biology.
Latest Patents
Matan holds a patent for "Effector proteins and methods of use." This patent encompasses compositions, systems, and methods that utilize effector proteins, which are shown to be active with guide RNAs. These proteins are characterized as CRISPR-associated (Cas) proteins. The patent outlines various compositions, systems, and methods that leverage the activities of these effector proteins for the modification, detection, and engineering of nucleic acids.
Career Highlights
Matan is currently employed at Mammoth Biosciences, Inc., where he continues to advance his research in the field of CRISPR technology. His work at the company focuses on developing innovative solutions that harness the power of effector proteins for various applications in genetic research and therapy.
Collaborations
Matan collaborates with talented individuals in his field, including Aaron DeLoughery and Lucas Benjamin Harrington. These collaborations enhance the research and development efforts at Mammoth Biosciences, Inc., fostering a creative environment for innovation.
Conclusion
Matan Drory Retwitzer is a pioneering inventor whose work in CRISPR technology is shaping the future of genetic engineering. His contributions through patents and collaborations are paving the way for advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile